Clinical Trial Update: Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update assessing the potential neuroprotective and neurotrophic effects of Lexapro (escitalopram) in patients with Posttraumatic Stress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: UNKNOWN